Wednesday, July 8, 2026
🇺🇸 FDA

biotech · Rheumatoid Arthritis · Pharmacokinetics · XBIT

XBiotech Germany

XBiotech Germany GmbH

XBiotech Germany patent portfolio — 31 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
Baesweiler, DE HQ
30 Employees
Public company Type
XBIT · NYSE Ticker
Company details
Status
Public
HQ
Baesweiler, DE
Employees
30
Programs
8
Drugs
6
Patents
31
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

XBiotech Germany patents

31 pharmaceutical patents indexed for XBiotech Germany. 0 expire within 24 months.

XBiotech Germany has 31 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

31 patents

Patent portfolio

  1. US 12116405

    Arthritis treatment

    Expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11932688

    Treatment for neoplastic diseases

    Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11773157

    Compositions and methods for treating and preventing Staphylococcus aureus infections

    Expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11529298

    Cosmetic composition and its use, dermocosmetic formulation

    Expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11523981

    Cosmetic composition and its use, dermocosmetic formulation

    Expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11370831

    Compositions and methods for treating and preventing Staphylococcus aureus infections

    Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10577410

    Compositions and methods for treating and preventing Staphylococcus aureus infections

    Expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10294296

    Treatment for neoplastic diseases

    Expires Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10214581

    Compositions and methods for treating and preventing Staphylococcus aureus infections

    Expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10202449

    Cachexia treatment

    Expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9988447

    Treatment of diabetes

    Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9902769

    Treatment of dermatological pathologies

    Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9840558

    Human antibody specific for interleukin-1alpha

    Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9809649

    Cachexia treatment

    Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9783598

    Compositions and methods for treating and preventing Staphylococcus aureus infections

    Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9724409

    Treatment of inflammatory skin disease

    Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9545441

    Treatment of diabetes

    Expires Mon Jan 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9486523

    Compositions and methods for treating and preventing Staphylococcus aureus infections

    Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9416172

    Compositions and methods for treating and preventing Staphylococcus aureus infections

    Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9181338

    Human antibody specific for IL-1alpha

    Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8962814

    Interleukin-1α antibodies and methods of use

    Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8956831

    Nucleic acids encoding a human monoclonal antibody that specifically binds to IL-1α

    Expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8865175

    Increasing anti-IL-1α antibodies in a subject

    Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8784817

    Method for killing IL-1 alpha expressing cells

    Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8679489

    Inhibiting cell migration

    Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8546331

    Modulation of pathogenic CD14+/CD16+ monocytes

    Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8388969

    Interleukin-1 alpha antibodies and methods of use

    Expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8388956

    Interleukin-1 alpha antibodies and methods of use

    Expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8242074

    Modulation of the amount or function of pathogenic CD14+CD16+ monocytes

    Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8187817

    Diagnosis, treatment, and prevention of vascular disorders using IL-1 autoantibodies

    Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8034337

    Interleukin-1α antibodies

    Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does XBiotech Germany have?

31 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do XBiotech Germany patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.